Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

The purpose of this long-term follow-up study is to assess the long-term health status of HIV-infected subjects who previously participated in GSK-sponsored trials evaluating the investigational HIV vaccine 732462. This study will provide additional data concerning the long-term benefits/risks associated with vaccination. No vaccine will be administered during the study period. Vaccines were administered during the primary studies.

General information on the health of the subject and persistence of the cellular and humoral immune responses to study vaccination will be evaluated.